Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-28 @ 6:41 PM
Study NCT ID:
NCT04001634
Status:
COMPLETED
Last Update Posted:
2024-02-26
First Post:
2019-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dual Anti-HER2 Therapy (Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive MBC
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-27
First Submit QC Date:
None
Study First Post Date:
2019-06-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-23
Last Update Post Date:
2024-02-26
Last Update Post Date Type:
ACTUAL